Previous studies have drawn a similar conclusion that oral administration of DEHP tends to increase the allergic response of animal atopic dermatitis models, and exhibits an adjuvant effect on allergen-specific Ig production, eosinophil infiltration and the local expression of inflammatory cytokines, such as IL-4, IL-13 [6, 48]. This evidence concerns the gene IL13 and atopic eczema.